Ocular Hypertension (Disease Or Phenotype)

Omim:MTHU067205

Nci:C3285

Msh:D009798

Mondo:MONDO:6875

Medcin:MEDCIN:36552

Mdr:MDR:10030043

Id:a1587f92-dd83-5583-b076-742783e795a0

Icpc2icd10eng:MTHU053876

Icd10cm:H40.05

Efo:EFO:1001069

Doid:DOID:9282

Chv:CHV:8892

Linked to

	Label	Description
	5-(3-tert-Butylamino-2-hydroxy-propoxy)-3,4-dihydro-1H-quinolin-2-one (carteolol) indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Omidenepag isopropyl indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Befunolol indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	latanoprost (isopropyl ester) indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	timolol indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	netarsudil indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	pilocarpine indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Levobunolol indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Paclitaxel indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	latanoprostene bunod indication Ocular Hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

5-(3-tert-Butylamino-2-hydroxy-propoxy)-3,4-dihydro-1H-quinolin-2-one (carteolol) indication Ocular Hypertension